Related Experiment Videos
CSF levels of cyclic nucleotides and adrenergic metabolites in malignant gliomas
Abstract:
Recent advances indicate that cyclic nucleotides and perhaps certain adrenergic metabolites might be directly involved in contact-inhibition mechanisms and tumoral cell growth. CSF levels of 3'-5' cAMP, 3'-5' cGMP, HVA, and 5-HIAA were investigated in patients with supratentorial malignant gliomas, brain stem gliomas and posterior fossa medulloblastoma. cAMP levels were slightly decreased only in medulloblastomas, whereas no significant difference was detectable in patients with supratentorial gliomas. cGMP values turned out to be significantly higher, with a very peculiar increase in the most anaplastic neoplasms. Postoperative follow-up showed a gradual decrease of cGMP values, with progressive restoring of a normal cAMP/cGMP ratio. The possible correlation of these findings with CSF levels of HVA and 5-HIAA is discussed.
Insights
Cyclic guanosine monophosphate (cGMP) levels are elevated in malignant gliomas, potentially indicating tumoral cell growth. Post-surgery, cGMP decreases, suggesting a correlation with tumor status and cyclic adenosine monophosphate (cAMP) levels.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Biochemistry
Background:
- Cyclic nucleotides and adrenergic metabolites may influence tumor cell growth and contact inhibition.
- Cerebrospinal fluid (CSF) levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) are potential biomarkers.
Purpose of the Study:
- To investigate CSF levels of cAMP, cGMP, homovanillic acid (HVA), and 5-hydroxyindoleacetic acid (5-HIAA) in patients with malignant gliomas.
- To explore the relationship between these biochemical markers and tumor characteristics/progression.
Main Methods:
- Measurement of CSF cAMP, cGMP, HVA, and 5-HIAA levels.
- Analysis of levels in patients with supratentorial malignant gliomas, brain stem gliomas, and posterior fossa medulloblastoma.
- Postoperative monitoring of cGMP and cAMP/cGMP ratio.
Main Results:
- Slightly decreased cAMP levels observed only in medulloblastomas.
- Significantly elevated cGMP levels found in malignant gliomas, particularly in anaplastic types.
- Postoperative decrease in cGMP and restoration of normal cAMP/cGMP ratio observed.
Conclusions:
- Elevated CSF cGMP levels correlate with malignant glioma presence and anaplasia.
- Changes in cAMP and cGMP levels may reflect tumor status and response to treatment.
- Further investigation into the role of cyclic nucleotides in glioma pathogenesis is warranted.